Background: The aim of this study was to investigate whether chronic kidney disease (CKD) predicts the outcome of the Functional Independence Measure (FIM) and the Korean version of the modified Barthel Index (K-MBI) 6 months after stroke with adjustment for age, gender, education, smoking, drinking, obesity, hypertension, diabetes mellitus, dyslipidemia, the FIM or K-MBI at discharge and the National Institutes of Health Stroke Scale (NIHSS) score 7 days post stroke. Methods: This study is an interim report of the Korean Stroke Cohort for Functioning and Rehabilitation. The sample included 2,037 ischemic stroke patients aged 18 years or older. The FIM and K-MBI scores were assessed at discharge and at 6 months after the onset of stroke. The estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. CKD was defined as an eGFR <60 ml/min/1.73 m2. Results: Overall, the mean age was 65.5 (±12.4) years. The proportion of men was 62.6%. The proportion of CKD cases was 12.7%. The means of the 6-month FIM and K-MBI were 109.8 (±27.9) and 87.0 (±26.4), respectively. In multiple linear regressions, the 6-month FIM after stroke was significantly associated with CKD (-2.85, p < 0.05), age (-0.29, p < 0.01), the FIM at discharge (0.46, p < 0.01) and the 7-day NIHSS score (-1.71, p < 0.01). Additionally, the post-stroke 6-month K-MBI was significantly associated with CKD (-2.88, p < 0.01), age (-0.27, p < 0.01), the K-MBI at discharge (0.46, p < 0.01) and the 7-day NIHSS score (-1.55, p < 0.01). Conclusions: This nationwide hospital-based cohort study showed that CKD might predict poor 6-month FIM and K-MBI scores in ischemic stroke patients.

Meguid El Nahas A, Bello AK: Chronic kidney disease: the global challenge. Lancet 2005;365:331-340.
Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T; FSR Investigators: Proteinuria and clinical outcomes after ischemic stroke. Neurology 2012;78:1909-1915.
Toyoda K, Ninomiya T: Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol 2014;13:823-833.
Yeh SJ, Jeng JS, Tang SC, Liu CH, Hsu SP, Chen CH, Lien LM, Lin HJ, Chen CM, Lin RT, Lee SP, Lin CH, Yeh CH, Sun Y, Sun MH, Yin JH, Lin CC, Wen CP, Tsai LK, Sung FC, Hsu CY; Taiwan Stroke Registry Investigators: Low estimated glomerular filtration rate is associated with poor outcomes in patients who suffered a large artery atherosclerosis stroke. Atherosclerosis 2015;239:328-334.
Kim HJ, Kim JK, Oh MS, Kim SG, Yu KH, Lee BC: A low baseline glomerular filtration rate predicts poor clinical outcome at 3 months after acute ischemic stroke. J Clin Neurol 2015;11:73-79.
Hsieh CY, Lin HJ, Sung SF, Hsieh HC, Lai EC, Chen CH: Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy? Cerebrovasc Dis 2014;37:51-56.
Toschke AM, Tilling K, Cox AM, Rudd AG, Heuschmann PU, Wolfe CD: Patient-specific recovery patterns over time measured by dependence in activities of daily living after stroke and post-stroke care: the South London Stroke Register (SLSR). Eur J Neurol 2010;17:219-225.
Kwakkel G, Kollen B, Twisk J: Impact of time on improvement of outcome after stroke. Stroke 2006;37:2348-2353.
Kwakkel G, Kollen BJ, Wagenaar RC: Long term effects of intensity of upper and lower limb training after stroke: a randomised trial. J Neurol Neurosurg Psychiatry 2002;72:473-479.
Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS: Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke 2009;40:2805-2811.
Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P; Oxfordshire Community Stroke Project the International Stroke Trial (UK); Lothian Stroke Register: Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008;336:376-379.
Toyoda K: The cerebro-renal interaction in stroke neurology. Neurology 2012;78:1898-1899.
Toyoda K: Cerebrorenal interaction and stroke. Contrib Nephrol 2013;179:1-6.
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G; National Kidney Foundation: National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147.
Ninomiya T, Perkovic V, Verdon C, Barzi F, Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC, Huxley R: Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis 2009;53:417-425.
Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010;341:c4249.
Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis 2011;31:123-129.
Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi M, Orion D, Sela BA, Tanne D: Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 2009;40:1296-1303.
Doyle EM, Sloan JM, Goodbrand JA, McMurdo ME, Donnan PT, McGilchrist MM, Frost H, Witham MD: Association between kidney function, rehabilitation outcome, and survival in older patients discharged from inpatient rehabilitation. Am J Kidney Dis 2015;pii:S0272-6386(15)00739-8.
Ovbiagele B, Sanossian N, Liebeskind DS, Kim D, Ali LK, Pineda S, Saver JL: Indices of kidney dysfunction and discharge outcomes in hospitalized stroke patients without known renal disease. Cerebrovasc Dis 2009;28:582-588.
Agrawal V, Rai B, Fellows J, McCullough PA: In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke. Nephrol Dial Transplant 2010;25:1150-1157.
Division of Policy for Persons with Disabilities: Criteria for the Classification of Disability. Sejong City, Ministry of Health and Welfare, 2013.
Division of Self-Suffocoency for Persons with Diablilites: 2015 Disabled Pension Project Guide. Sejong City, Ministry of Health and Welfare, 2015.
Ones K, Yalcinkaya EY, Toklu BC, Caglar N: Effects of age, gender, and cognitive, functional and motor status on functional outcomes of stroke rehabilitation. NeuroRehabilitation 2009;25:241-249.
Brown AW, Therneau TM, Schultz BA, Niewczyk PM, Granger CV: Measure of functional independence dominates discharge outcome prediction after inpatient rehabilitation for stroke. Stroke 2015;46:1038-1044.
Joa KL, Han TR, Pyun SB, Rah UW, Park JH, Kim YH, Chun MH, Paik NJ, Yoo SD, Lee SG, Park SW, Lim SH, Jung HY: Inpatient stroke rehabilitation outcomes in Korea derived from the Korean brain rehabilitation centers' online database system for the years 2007 to 2011. J Korean Med Sci 2015;30:644-650.
Baltan S, Besancon EF, Mbow B, Ye Z, Hamner MA, Ransom BR: White matter vulnerability to ischemic injury increases with age because of enhanced excitotoxicity. J Neurosci 2008;28:1479-1489.
Baltan S: Ischemic injury to white matter: an age-dependent process. Neuroscientist 2009;15:126-133.
Rosenzweig S, Carmichael ST: Age-dependent exacerbation of white matter stroke outcomes: a role for oxidative damage and inflammatory mediators. Stroke 2013;44:2579-2586.
Denti L, Agosti M, Franceschini M: Outcome predictors of rehabilitation for first stroke in the elderly. Eur J Phys Rehabil Med 2008;44:3-11.
Gialanella B, Santoro R, Ferlucci C: Predicting outcome after stroke: the role of basic activities of daily living predicting outcome after stroke. Eur J Phys Rehabil Med 2013;49:629-637.
Duarte E, Marco E, Muniesa JM, Belmonte R, Aguilar JJ, Escalada F: Early detection of non-ambulatory survivors six months after stroke. NeuroRehabilitation 2010;26:317-323.
Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP: Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013;382:339-352.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.